|
1
|
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM
and Wallace MB: Colorectal cancer. Lancet. 394:1467–1480. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Patel SG and Ahnen DJ: Colorectal cancer
in the young. Curr Gastroenterol Rep. 20:152018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weitz J, Koch M, Debus J, Höhler T, Galle
PR and Büchler MW: Colorectal cancer. Lancet. 365:153–165. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Connell LC, Mota JM, Braghiroli MI and
Hoff PM: The rising incidence of younger patients with colorectal
cancer: Questions about screening, biology, and treatment. Curr
Treat Options Oncol. 18:232017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Castells A: Hereditary forms of colorectal
cancer. Gastroenterol Hepatol. 39 (Suppl 1):S62–S67. 2016.(In
English, Spanish). View Article : Google Scholar
|
|
6
|
Wrobel P and Ahmed S: Current status of
immunotherapy in metastatic colorectal cancer. Int J Colorectal
Dis. 34:13–25. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Paraskevopoulou MD and Hatzigeorgiou AG:
Analyzing MiRNA- LncRNA interactions. Methods Mol Biol.
1402:271–286. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kumar MM and Goyal R: LncRNA as a
therapeutic target for angiogenesis. Curr Top Med Chem.
17:1750–1757. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Charles Richard JL and Eichhorn PJA:
Platforms for investigating LncRNA functions. SLAS Technol.
23:493–506. 2018.PubMed/NCBI
|
|
10
|
Qian X, Zhao J, Yeung PY, Zhang QC and
Kwok CK: Revealing lncRNA structures and interactions by
sequencing-based approaches. Trends Biochem Sci. 44:33–52. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma Y, Zhang J, Wen L and Lin A:
Membrane-lipid associated lncRNA: A new regulator in cancer
signaling. Cancer Lett. 419:27–29. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang HV and Chekanova JA: Long noncoding
RNAs in plants. Adv Exp Med Biol. 1008:133–154. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou H, Mangelsdorf M, Liu J, Zhu L and Wu
JY: RNA-binding proteins in neurological diseases. Sci China Life
Sci. 57:432–444. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lujan DA, Ochoa JL and Hartley RS:
Cold-inducible RNA binding protein in cancer and inflammation.
Wiley Interdiscip Rev RNA. 9:10.1002/wrna.1462. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Köster T, Marondedze C, Meyer K and
Staiger D: RNA-binding proteins revisited-the emerging arabidopsis
mRNA interactome. Trends Plant Sci. 22:512–526. 2017. View Article : Google Scholar
|
|
16
|
Ferrè F, Colantoni A and Helmer-Citterich
M: Revealing protein-lncRNA interaction. Brief Bioinform.
17:106–116. 2016. View Article : Google Scholar
|
|
17
|
Panda AC, Martindale JL and Gorospe M:
Affinity pulldown of biotinylated RNA for detection of protein-RNA
complexes. Bio Protoc. 6:e20622016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cao L, Zhang P, Li J and Wu M: LAST, a
c-Myc-inducible long noncoding RNA, cooperates with CNBP to promote
CCND1 mRNA stability in human cells. Elife. 6:e304332017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gong C and Maquat LE: lncRNAs
transactivate STAU1-mediated mRNA decay by duplexing with 3′ UTRs
via Alu elements. Nature. 470:284–288. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Su W, Wang L, Niu F, Zou L, Guo C, Wang Z,
Yang X, Wu J, Lu Y, Zhang J, et al: LINC00857 knockdown inhibits
cell proliferation and induces apoptosis via involving STAT3 and
MET oncogenic proteins in esophageal adenocarcinoma. Aging (Albany
NY). 11:2812–2821. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xia C, Zhang XY, Liu W, Ju M, Ju Y, Bu YZ,
Wang W and Shao H: LINC00857 contributes to hepatocellular
carcinoma malignancy via enhancing epithelial-mesenchymal
transition. J Cell Biochem. Dec 3–2018.(Epub ahead of print).
|
|
22
|
Dudek AM, van Kampen JG, Witjes JA,
Kiemeney LA and Verhaegh GW: LINC00857 expression predicts and
mediates the response to platinum-based chemotherapy in
muscle-invasive bladder cancer. Cancer Med. 7:3342–3350. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fléjou JF: WHO classification of digestive
tumors: The fourth edition. Ann Pathol. 31 (Suppl 5):S27–S31.
2011.(In French). View Article : Google Scholar
|
|
24
|
Gaspersz MP, Buettner S, van Vugt JL, de
Jonge J, Polak WG, Doukas M, Ijzermans JNM, Koerkamp BG and
Willemssen FE: Evaluation of the new American joint committee on
cancer staging manual 8th edition for perihilar cholangiocarcinoma.
J Gastrointest Surg. 24:1612–1618. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Carlevaro-Fita J and Johnson R: Global
positioning system: Understanding long noncoding RNAs through
subcellular localization. Mol Cell. 73:869–883. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Z, Chao TC, Chang KY, Lin N, Patil VS,
Shimizu C, Head SR, Burns JC and Rana TM: The long noncoding RNA
THRIL regulates TNFα expression through its interaction with
hnRNPL. Proc Natl Acad Sci USA. 111:1002–1007. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Anders G, Mackowiak SD, Jens M, Maaskola
J, Kuntzagk A, Rajewsky N, Landthaler M and Dieterich C: doRiNA: A
database of RNA interactions in post-transcriptional regulation.
Nucleic Acids Res. 40:D180–D186. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mura M, Hopkins TG, Michael T, Abd-Latip
N, Weir J, Aboagye E, Mauri F, Jameson C, Sturge J, Gabra H, et al:
LARP1 post-transcriptionally regulates mTOR and contributes to
cancer progression. Oncogene. 34:5025–5036. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Galgano A, Forrer M, Jaskiewicz L, Kanitz
A, Zavolan M and Gerber AP: Comparative analysis of mRNA targets
for human PUF-family proteins suggests extensive interaction with
the miRNA regulatory system. PLoS One. 3:e31642008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu S, Li G, Li Q, Zhang Q, Zhuo L, Chen
X, Zhai B, Sui X, Chen K and Xie T: The roles and mechanisms of YTH
domain-containing proteins in cancer development and progression.
Am J Cancer Res. 10:1068–1084. 2020.PubMed/NCBI
|
|
32
|
Xiao W, Adhikari S, Dahal U, Chen YS, Hao
YJ, Sun BF, Sun HY, Li A, Ping XL, Lai WY, et al: Nuclear m(6)A
reader YTHDC1 regulates mRNA splicing. Mol Cell. 61:507–519. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tanabe A, Tanikawa K, Tsunetomi M, Takai
K, Ikeda H, Konno J, Torigoe T, Maeda H, Kutomi G, Okita K, et al:
RNA helicase YTHDC2 promotes cancer metastasis via the enhancement
of the efficiency by which HIF-1α mRNA is translated. Cancer Lett.
376:34–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tanabe A, Konno J, Tanikawa K and Sahara
H: Transcriptional machinery of TNF-α-inducible YTH domain
containing 2 (YTHDC2) gene. Gene. 535:24–32. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fanale D, Iovanna JL, Calvo EL, Berthezene
P, Belleau P, Dagorn JC, Bronte G, Cicero G, Bazan V, Rolfo C, et
al: Germline copy number variation in the YTHDC2 gene: Does it have
a role in finding a novel potential molecular target involved in
pancreatic adenocarcinoma susceptibility? Expert Opin Ther Targets.
18:841–850. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kasowitz SD, Ma J, Anderson SJ, Leu NA, Xu
Y, Gregory BD, Schultz RM and Wang PJ: Nuclear m6A reader YTHDC1
regulates alternative polyadenylation and splicing during mouse
oocyte development. PLoS Genet. 14:e10074122018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu X, Liu L, Dong Z, Li J, Yu Y, Chen X,
Ren F, Cui G and Sun R: Expression patterns and prognostic value of
m6A-related genes in colorectal cancer. Am J Transl Res.
11:3972–3991. 2019.PubMed/NCBI
|
|
38
|
Popova VV, Kurshakova MM and Kopytova DV:
Methods to study the RNA-protein interactions. Mol Biol (Mosk).
49:472–481. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sakata T, Ferdous G, Tsuruta T, Satoh T,
Baba S, Muto T, Ueno A, Kanai Y, Endou H and Okayasu I: L-type
amino-acid transporter 1 as a novel biomarker for high-grade
malignancy in prostate cancer. Pathol Int. 59:7–18. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kaira K, Oriuchi N, Imai H, Shimizu K,
Yanagitani N, Sunaga N, Hisada T, Tanaka S, Ishizuka T, Kanai Y, et
al: Prognostic significance of L-type amino acid transporter 1
expression in resectable stage I–III nonsmall cell lung cancer. Br
J Cancer. 98:742–748. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang L, Cao L, Wen C, Li J, Yu G and Liu
C: LncRNA LINC00857 regulates lung adenocarcinoma progression,
apoptosis and glycolysis by targeting miR-1179/SPAG5 axis. Hum
Cell. 33:195–204. 2020. View Article : Google Scholar : PubMed/NCBI
|
